Knowledge, attitudes, and practices of cervical cancer prevention and pap smears in two low-income communities in Lima, Peru.
Cervical cancer
KAP
Peri-urban
Peru
Shantytown
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
21 04 2021
21 04 2021
Historique:
received:
19
09
2018
accepted:
30
03
2021
entrez:
22
4
2021
pubmed:
23
4
2021
medline:
1
6
2021
Statut:
epublish
Résumé
Cervical cancer is a leading cause of death among Peruvian women. Barriers at multiple levels impact effective screening and treatment, including a lack of knowledge about cervical cancer and how regular screening can reduce morbidity and mortality through earlier detection. The aim of this study is to assess knowledge, attitudes, and practices regarding cervical cancer and its prevention in the peri-urban communities of Oasis and Pampas in southern Lima, Peru that can be used to inform future campaigns about cervical cancer prevention. A cross-sectional survey that included several open-ended questions was administered to women in Pampas and Oasis between 2015 and 2016 to evaluate the knowledge, attitudes, and practices regarding cervical cancer and Pap smears. In total, 224 women were interviewed. Knowledge about cervical cancer and Pap smears was high, and attitudes were predominantly positive among most participants. Most participants knew how often they should get Pap smears (89.7%), when to begin seeking screening (74.6%), knew the price of a Pap smear (61.9%), and felt Pap smears were important for their health (70.1%). About one third (29.5%) of premenopausal women reported receiving a Pap smear in the last year. However, open ended questions revealed some knowledge gaps around Pap smears, as well as some stigma associated to Human Papilloma Virus (HPV) infection. Although knowledge of cervical cancer prevention was generally high and perceptions were positive among women in peri-urban Peruvian communities, our findings revealed there is a need for education on HPV infection prevalence among sexually active individuals to reduce stigma. Future research should focus on exploring experiences with follow-up and treatment associated with abnormal Pap smears, as well as perspectives from health authorities and professionals about barriers in the early detection and treatment process for cervical cancer.
Sections du résumé
BACKGROUND
Cervical cancer is a leading cause of death among Peruvian women. Barriers at multiple levels impact effective screening and treatment, including a lack of knowledge about cervical cancer and how regular screening can reduce morbidity and mortality through earlier detection. The aim of this study is to assess knowledge, attitudes, and practices regarding cervical cancer and its prevention in the peri-urban communities of Oasis and Pampas in southern Lima, Peru that can be used to inform future campaigns about cervical cancer prevention.
METHODS
A cross-sectional survey that included several open-ended questions was administered to women in Pampas and Oasis between 2015 and 2016 to evaluate the knowledge, attitudes, and practices regarding cervical cancer and Pap smears.
RESULTS
In total, 224 women were interviewed. Knowledge about cervical cancer and Pap smears was high, and attitudes were predominantly positive among most participants. Most participants knew how often they should get Pap smears (89.7%), when to begin seeking screening (74.6%), knew the price of a Pap smear (61.9%), and felt Pap smears were important for their health (70.1%). About one third (29.5%) of premenopausal women reported receiving a Pap smear in the last year. However, open ended questions revealed some knowledge gaps around Pap smears, as well as some stigma associated to Human Papilloma Virus (HPV) infection.
CONCLUSION
Although knowledge of cervical cancer prevention was generally high and perceptions were positive among women in peri-urban Peruvian communities, our findings revealed there is a need for education on HPV infection prevalence among sexually active individuals to reduce stigma. Future research should focus on exploring experiences with follow-up and treatment associated with abnormal Pap smears, as well as perspectives from health authorities and professionals about barriers in the early detection and treatment process for cervical cancer.
Identifiants
pubmed: 33882904
doi: 10.1186/s12905-021-01291-8
pii: 10.1186/s12905-021-01291-8
pmc: PMC8059236
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
168Subventions
Organisme : NIMHD NIH HHS
ID : T37 MD001424
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009340
Pays : United States
Références
Health Educ Behav. 2003 Jun;30(3):337-59
pubmed: 19731500
Am J Health Promot. 2000 May-Jun;14(5):292-300
pubmed: 11009855
PLoS One. 2012;7(10):e48017
pubmed: 23144719
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
Am J Hum Biol. 2004 Jul-Aug;16(4):395-404
pubmed: 15214058
Br J Gen Pract. 1998 Aug;48(433):1509-14
pubmed: 10024713
J Womens Health (Larchmt). 2011 Jun;20(6):943-52
pubmed: 21671779
Sex Transm Infect. 2007 Apr;83(2):155-9
pubmed: 17098767
J Adv Pract Oncol. 2014 Jan;5(1):31-41
pubmed: 25032031
Salud Publica Mex. 2003;45 Suppl 3:S306-14
pubmed: 14746023
Lancet Oncol. 2017 Oct;18(10):e595-e606
pubmed: 28971826
Front Public Health. 2014 Dec 22;2:281
pubmed: 25566523
Int J Gynecol Cancer. 2002 Sep-Oct;12(5):475-9
pubmed: 12366665
Nurs Outlook. 1997 Jan-Feb;45(1):16-22
pubmed: 9139258
Am J Trop Med Hyg. 2013 Sep;89(3):507-15
pubmed: 23878185
BMC Public Health. 2016 Feb 24;16:181
pubmed: 26911388
Lancet Oncol. 2012 Aug;13(8):790-801
pubmed: 22658655
Int Q Community Health Educ. 2010-2011;31(3):245-63
pubmed: 21988870
J Allergy Clin Immunol. 2011 Apr;127(4):875-82
pubmed: 21237505
Patient Prefer Adherence. 2016 Oct 18;10:2107-2116
pubmed: 27799747
Vaccine. 2008 Aug 19;26 Suppl 11:iii-iv
pubmed: 18945408
East Mediterr Health J. 2011 Nov;17(11):855-61
pubmed: 22276494
Reprod Health Matters. 2012 Dec;20(40):49-58
pubmed: 23245408
Vaccine. 2008 Aug 19;26 Suppl 11:v-vi
pubmed: 18945409
Am J Prev Med. 1998 Apr;14(3):201-8
pubmed: 9569221
Int J Epidemiol. 2008 Aug;37(4):862-9
pubmed: 18653515
Obstet Gynecol Clin North Am. 2007 Dec;34(4):739-60, ix
pubmed: 18061867
Salud Publica Mex. 2003;45 Suppl 3:S315-25
pubmed: 14746024
J Low Genit Tract Dis. 2010 Apr;14(2):113-7
pubmed: 20354419
Salud Publica Mex. 2019 Jul-Ago;61(4):456-460
pubmed: 31430087